Point72 Asset Management »

X4 Pharmaceuticals shares owned by Point72 Asset Management

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $74k 22k 3.42
2025-06-30 $41k 22k 1.90

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Arista Networks Com Shs (ANET)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Biogen Idec (BIIB)
Meta Platforms Cl A (META)
Teradyne (TER)
Advanced Micro Devices (AMD)
Asml Holding N V N Y Registry Shs (ASML)
Broadcom (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Airbnb Com Cl A (ABNB)

View all positions for Point72 Asset Management

Top funds holding X4 Pharmaceuticals

Bain Capital Life Sciences Investors
BVF
Nantahala Capital Management
Rosalind Advisors
Deep Track Capital
Stonepine Capital Management
Kingdon Capital Management
Stempoint Capital
Vanguard Group
Boothbay Fund Management
Pale Fire Capital SE
UBS Group
Susquehanna International
Palumbo Wealth Management
Geode Capital Management

View all funds holding X4 Pharmaceuticals